| Key Financial Ratios of IOL Chemicals and Pharmaceuticals (in Rs. Cr.) |
Mar 15 |
Mar 14 |
Mar 13 |
Mar 12 |
Mar 11 |
|
| Per Share Ratios |
|
|
|
|
|
|
| Basic EPS (Rs.) |
-16.72 |
1.21 |
0.61 |
1.85 |
2.52 |
|
| Diluted EPS (Rs.) |
-16.72 |
1.21 |
0.61 |
1.85 |
2.52 |
|
| Cash EPS (Rs.) |
-7.92 |
12.12 |
12.60 |
11.16 |
11.64 |
|
| Book Value [ExclRevalReserve]/Share (Rs.) |
43.48 |
65.67 |
64.24 |
65.39 |
65.07 |
|
| Book Value [InclRevalReserve]/Share (Rs.) |
43.48 |
65.67 |
64.24 |
65.39 |
65.07 |
|
| Dividend / Share(Rs.) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Revenue from Operations/Share (Rs.) |
80.73 |
195.56 |
184.13 |
183.03 |
151.42 |
|
| PBDIT/Share (Rs.) |
2.64 |
33.68 |
35.02 |
27.58 |
27.07 |
|
| PBIT/Share (Rs.) |
-3.43 |
22.71 |
23.02 |
18.27 |
17.82 |
|
| PBT/Share (Rs.) |
-15.83 |
1.76 |
1.13 |
1.48 |
3.52 |
|
| Net Profit/Share (Rs.) |
-13.99 |
1.15 |
0.61 |
1.85 |
2.40 |
|
| Profitability Ratios |
|
|
|
|
|
|
| PBDIT Margin (%) |
3.26 |
17.22 |
19.01 |
15.07 |
17.87 |
|
| PBIT Margin (%) |
-4.24 |
11.61 |
12.50 |
9.98 |
11.77 |
|
| PBT Margin (%) |
-19.60 |
0.90 |
0.61 |
0.80 |
2.32 |
|
| Net Profit Margin (%) |
-17.32 |
0.58 |
0.32 |
1.00 |
1.58 |
|
| Return on Networth / Equity (%) |
-32.16 |
1.74 |
0.94 |
2.82 |
3.69 |
|
| Return on Capital Employed (%) |
-13.51 |
0.69 |
0.31 |
1.02 |
1.46 |
|
| Return on Assets (%) |
-9.49 |
0.44 |
0.21 |
0.69 |
1.02 |
|
| Total Debt/Equity (X) |
1.92 |
1.65 |
2.29 |
2.09 |
1.78 |
|
| Asset Turnover Ratio (%) |
54.83 |
76.03 |
66.24 |
68.51 |
64.59 |
|
| Liquidity Ratios |
|
|
|
|
|
|
| Current Ratio (X) |
1.36 |
1.04 |
1.10 |
0.88 |
0.99 |
|
| Quick Ratio (X) |
0.34 |
0.33 |
0.38 |
0.30 |
0.43 |
|
| Inventory Turnover Ratio (X) |
1.80 |
2.93 |
2.95 |
3.57 |
3.91 |
|
| Dividend Payout Ratio (NP) (%) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Dividend Payout Ratio (CP) (%) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Earnings Retention Ratio (%) |
0.00 |
100.00 |
100.00 |
100.00 |
100.00 |
|
| Cash Earnings Retention Ratio (%) |
0.00 |
100.00 |
100.00 |
100.00 |
100.00 |
|
| Valuation Ratios |
|
|
|
|
|
|
| Enterprise Value (Cr.) |
521.61 |
377.14 |
441.59 |
410.13 |
382.85 |
|
| EV/Net Operating Revenue (X) |
1.36 |
0.67 |
0.92 |
0.87 |
0.98 |
|
| EV/EBITDA (X) |
41.47 |
3.89 |
4.82 |
5.78 |
5.50 |
|
| MarketCap/Net Operating Revenue (X) |
0.36 |
0.10 |
0.13 |
0.13 |
0.25 |
|
| Retention Ratios (%) |
0.00 |
100.00 |
100.00 |
100.00 |
100.00 |
|
| Price/BV (X) |
0.66 |
0.29 |
0.39 |
0.37 |
0.58 |
|
| Price/Net Operating Revenue |
0.36 |
0.10 |
0.13 |
0.13 |
0.25 |
|
| Earnings Yield |
-0.49 |
0.06 |
0.02 |
0.08 |
0.06 |
|
Source : Dion Global Solutions Limited
